relative to notice requirements and enforcement for pharmacies dispensing medications intended to induce chemical abortions.
Committee Report: Inexpedient to Legislate 02/13/2026 (Vote 17-0; RC) HC 10 P. 102
Email me when HB 1702 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track HB 1702. By continuing you agree to the Terms and Privacy Policy.
Summary
The bill would force any New Hampshire pharmacy, hospital, clinic, or private office that provides mifepristone or other chemical‑abortion drugs to display a standardized notice informing patients that the drug’s effects might be reversible if the second pill has not been taken. It also creates a Class B felony for knowingly failing to post the notice and lets women sue for damages if they were not warned. The measure was rejected by the Judiciary Committee.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about HB 1702
3 free questions a day, no accountHistory
- Committee Report: Inexpedient to Legislate 02/13/2026 (Vote 17-0; RC) HC 10 P. 102
- Public Hearing: 02/09/2026 01:00 pm GP 158
- Executive Session: 02/13/2026 10:00 am GP 158
- Introduced 01/07/2026 and referred to Judiciary HJ 1 P. 32
Sponsors
- Samuel Farrington · sponsor
- Cindy Lynn Bennett
- James R Thibault
- Jeanine M Notter
- John Sellers
- Kevin A. Avard
- Kristine Perez
- Mark A Pearson
- Matt R Sabourin dit Choinière
- Maureen C. Mooney
- Samuel G Farrington
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when HB 1702 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HB 1702 freeOr ask your AI assistant about HB 1702 directly:
Add to Claude, ChatGPT or Cursor